BMY vs TT · P/E 17, rev $24.46B vs P/E 36, rev $11.32B
Bristol-Myers Squibb Company (BMY) versus Trane Technologies plc (TT) — a side-by-side from cached financials, not a winner call.
Bristol-Myers Squibb Company (BMY) is a drug manufacturers - general company listed on US. It is led by Chris Boerner.
Trane Technologies plc (TT) is a building products & equipment company listed on NYSE.
Latest reported BMY revenue for 2026-06-30 was $24.46B. Net income was $5.99B. BMY currently screens at market cap $95.36B and trailing P/E 17.5.
Latest reported TT revenue for 2026-06-30 was $11.32B. Net income was $1.51B. TT currently screens at market cap $104.45B and trailing P/E 36.2.
BMY currently screens at market cap $95.36B and trailing P/E 17.5. TT currently screens at market cap $104.45B and trailing P/E 36.2.
Not investment advice. Open the BMY and TT stock pages for the full models.
Not investment advice.